Innovation Services
MassBio Innovation Services (MBIS) is a suite of services offered through MassBio designed to increase the throughput of technology out of laboratories and into commerce. MBIS aims to facilitate the license or acquisition of technology, create opportunities for face to face interaction around deal making and capital access, and expand members' business network within the biotechnology ecosystem.
Why Innovation Services and Why Now?
MassBio’s 2015 Strategic Report and other analysis of the Massachusetts biotechnology supercluster identified the need to better align the research community with opportunities for commercialization, ie: connect the "buyers" with the "sellers". Innovation Services leverage the strength of the MassBio network to connect decision-makers seeking to collaborate and accelerate innovation.
Innovation Services is comprised of
- Pharma Days
- MassCONNECT
- Investors Forum
- Innovators Roundtable
- Innovation Exchange
About MassBio
MassBio is a not-for-profit organization committed to advancing the development of critical new science, technology and medicines that benefit people worldwide.
Founded in 1985, MassBio represents over 600 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and health care, and works to advance policy and promote education, while providing member programs and events, industry information, and services.
Latest Updates
- February 22, 2012 Finance: Biotechnology 2012 - The New Normal?
- February 22, 2012 What has made Massachusetts a better place for biotech? Make your nomination by Feb. 24th!
- February 16, 2012 MassBio Purchasing Consortium Augments Four Major Agreements
- February 15, 2012 HR & Finance: New 401(k) Rules Require Immediate Attention
- February 15, 2012 LSI & LRIG: Translational Informatics: Challenges and Opportunities